NCT00683462View on ClinicalTrials.gov

An Exploratory Trial of AZD3480 (TC-1734) for the Treatment of Adult Attention-Deficit/Hyperactivity Disorder (ADHD)

PHASE2CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

May 31, 2008

Study Completion Date

July 31, 2009

Conditions

ADHD

Interventions

DRUG

Placebo

DRUG

AZD3480

Capsules 5 mg/day (once a day) for 2 weeks

DRUG

AZD3480

Capsules 50 mg/day (once a day) for 2 weeks

Trial Locations (1)

Unknown

Research Site, Burlington

Sponsors

Lead Sponsor

All Listed Sponsors

collaborator

Targacept Inc.

INDUSTRY

lead

AstraZeneca

INDUSTRY